Cellceutix touts possible psoriasis treatment Boston messenger By Ira Kantor Beverly biopharmaceutical company Cellceutix Corp. announced plans today to meet with the United States of America Food and Drug management to discuss its pre-investigational new drug submission connected Prurisol, a potential attention for psoriasis . FDA Schedules Meeting With Cellceutix on New Psoriasis Drug MarketWatch (press release) Cellceutix gets FDA meeting connected psoriasis drug Mass advanced Tech FDA schedules assemblage with Cellceutix on disease of the skin drug Boston.com all vii news articles » Link To Article
No comments:
Post a Comment